No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Top 3 Health Care Stocks That May Explode In Q4
Insider Traders Lose UK£124k As Silence Therapeutics Drops
Institutional Owners May Take Dramatic Actions as Silence Therapeutics Plc's (NASDAQ:SLN) Recent 22% Drop Adds to One-year Losses
European Equities Traded in the US as American Depositary Lower in Tuesday Trading
The Analyst Landscape: 6 Takes On Silence Therapeutics
Silence Therapeutics Is Maintained at Buy by Chardan Capital